Kymera Therapeutics, Inc. - KYMR

Sector: Healthcare · Industry: Biological Products, (No Diagnostic Substances)

Website: No information yet · Social: No information yet

Company profile

Latest / Compare

Q1 2026 · Q4 2025

Value (USD)

Total reported value ($000)

$8.557B

QoQ value delta ($000)

+$1.583B (+22.7%)

Implied price effect (QoQ)

+6.51%

Total shares

103,257,312

QoQ shares delta

+13,619,146 (+15.19%)

Total shares held by funds (by quarter)

Interactive chart by TradingView.

Top 25 only Full list

Partial Q1 2026 data: 260 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.

Manager	Value ($000)	Shares	% of 13F
FMR LLC	974,488	11,699,950	0.05%
BAKER BROS. ADVISORS LP	721,061	8,657,242	4.14%
Avoro Capital Advisors LLC	622,571	7,474,747	6.12%
PRICE T ROWE ASSOCIATES INC /MD/	504,809	6,060,847	0.06%
VANGUARD GROUP INC	487,685	6,267,644	0.01%
BVF INC/IL	458,320	5,502,710	14.6%
T. Rowe Price Investment Management, Inc.	455,180	5,464,997	0.31%
BlackRock, Inc.	421,520	5,060,876	0.01%
Atlas Venture Life Science Advisors, LLC	381,302	4,578,008	48.26%
WELLINGTON MANAGEMENT GROUP LLP	323,972	3,889,687	0.06%
Siren, L.L.C.	265,431	3,186,830	7.36%
VANGUARD CAPITAL MANAGEMENT LLC	239,902	2,880,324	0.01%
VANGUARD PORTFOLIO MANAGEMENT LLC	239,380	2,874,056	0.01%
STATE STREET CORP	199,043	2,389,767	0.01%
Capital Research Global Investors	139,367	1,673,275	0.02%
GEODE CAPITAL MANAGEMENT, LLC	137,066	1,645,350	0.01%
DRIEHAUS CAPITAL MANAGEMENT LLC	86,920	1,043,583	0.64%
UBS Group AG	85,276	1,023,852	0.01%
GOLDMAN SACHS GROUP INC	73,995	888,409	0.01%
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	72,951	875,872	0.02%
Holocene Advisors, LP	69,693	836,759	0.17%
ALLIANCEBERNSTEIN L.P.	69,098	888,035	0.02%
Merck & Co., Inc.	64,313	772,165	18.4%
FRONTIER CAPITAL MANAGEMENT CO LLC	63,287	759,848	0.65%
Commodore Capital LP	62,467	750,000	3.61%